• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

解读 COVID-19 中细胞因子数据的挑战影响患者的护理和管理。

Challenges in interpreting cytokine data in COVID-19 affect patient care and management.

机构信息

Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.

Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America.

出版信息

PLoS Biol. 2021 Aug 6;19(8):e3001373. doi: 10.1371/journal.pbio.3001373. eCollection 2021 Aug.

DOI:10.1371/journal.pbio.3001373
PMID:34358229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8372945/
Abstract

Challenges in using cytokine data are limiting Coronavirus Disease 2019 (COVID-19) patient management and comparison among different disease contexts. We suggest mitigation strategies to improve the accuracy of cytokine data, as we learn from experience gained during the COVID-19 pandemic.

摘要

使用细胞因子数据面临的挑战限制了 2019 年冠状病毒病（COVID-19）患者的管理和不同疾病环境之间的比较。我们建议采取缓解策略来提高细胞因子数据的准确性，因为我们从 COVID-19 大流行期间获得的经验中学习。

相似文献

1
Challenges in interpreting cytokine data in COVID-19 affect patient care and management.解读 COVID-19 中细胞因子数据的挑战影响患者的护理和管理。
PLoS Biol. 2021 Aug 6;19(8):e3001373. doi: 10.1371/journal.pbio.3001373. eCollection 2021 Aug.
2
Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.细胞因子风暴：COVID-19 恶化的病理生理演变的主要决定因素。
Front Immunol. 2021 Apr 28;12:589095. doi: 10.3389/fimmu.2021.589095. eCollection 2021.
3
A Community-Based Model to the COVID-19 Humanitarian Crisis.基于社区的应对 COVID-19 人道主义危机模式。
Front Cell Infect Microbiol. 2021 Mar 15;11:639579. doi: 10.3389/fcimb.2021.639579. eCollection 2021.
4
Immunology Lessons from the SARS-CoV-2 Pandemic.来自新冠疫情的免疫学经验教训。
Annu Rev Immunol. 2021 Apr 26;39:v-vii. doi: 10.1146/annurev-iy-39-030121-100001. Epub 2021 May 3.
5
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.新型冠状病毒肺炎与肝损伤：肝脏作为这场大流行“新剧”的主角。
Scand J Immunol. 2021 Mar;93(3):e12977. doi: 10.1111/sji.12977. Epub 2020 Sep 26.
6
Autophagy/virophagy: a "disposal strategy" to combat COVID-19.自噬/噬病毒作用：一种对抗 COVID-19 的“处置策略”。
Autophagy. 2020 Dec;16(12):2271-2272. doi: 10.1080/15548627.2020.1782022. Epub 2020 Jun 24.
7
An Interview with Pei-Yong Shi, PhD.对裴勇（音译）博士的采访
J Interferon Cytokine Res. 2021 Jun;41(6):197-199. doi: 10.1089/jir.2021.29022.exp.
8
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.在细胞因子释放综合征背景下 SARS-CoV-2 感染的诊断。
Expert Rev Mol Diagn. 2020 Nov;20(11):1087-1097. doi: 10.1080/14737159.2020.1830760. Epub 2020 Oct 12.
9
Molecular Insights into COVID-19 Pathophysiology, Immune Pathogenesis, Detection, and Treatment.对 COVID-19 病理生理学、免疫发病机制、检测和治疗的分子洞察。
DNA Cell Biol. 2021 Jul;40(7):858-868. doi: 10.1089/dna.2021.0068. Epub 2021 May 14.
10
Management of haemophilia patients in the COVID-19 pandemic: Experience in Wuhan and Tianjin, two differently affected cities in China.COVID-19 大流行期间血友病患者的管理：中国受影响程度不同的两个城市武汉和天津的经验。
Haemophilia. 2020 Nov;26(6):1031-1037. doi: 10.1111/hae.14108. Epub 2020 Sep 6.

引用本文的文献

1
Predictive Role and Clinical Value of Serum Cytokines in COVID-19.血清细胞因子在新型冠状病毒肺炎中的预测作用及临床价值
Infect Dis Clin Microbiol. 2024 Dec 19;6(4):258-267. doi: 10.36519/idcm.2024.367. eCollection 2024 Dec.
2
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations.纤维蛋白原样微血栓和血小板病理如何应用于临床研究的观点。
Semin Thromb Hemost. 2024 Jun;50(4):537-551. doi: 10.1055/s-0043-1774796. Epub 2023 Sep 25.
3
Differential absolute plasma IL-6 concentrations between two immunoassay platforms in intensive care unit patients with COVID-19.新冠肺炎重症监护病房患者两种免疫检测平台间白细胞介素 6 血浆绝对浓度的差异。
Biomark Med. 2023 May;17(9):459-464. doi: 10.2217/bmm-2023-0073. Epub 2023 Aug 31.
4
Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.严重 COVID-19 中促炎细胞因子特征的描述。
Front Immunol. 2023 Mar 30;14:1170012. doi: 10.3389/fimmu.2023.1170012. eCollection 2023.
5
Human cardiac organoids to model COVID-19 cytokine storm induced cardiac injuries.利用人类心脏类器官模型研究 COVID-19 细胞因子风暴引起的心脏损伤。
J Tissue Eng Regen Med. 2022 Sep;16(9):799-811. doi: 10.1002/term.3327. Epub 2022 Jun 11.

本文引用的文献

1
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.托法替布治疗因 COVID-19 肺炎住院的患者。
N Engl J Med. 2021 Jul 29;385(5):406-415. doi: 10.1056/NEJMoa2101643. Epub 2021 Jun 16.
2
Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.重度新冠肺炎肺炎和全身炎症反应患者使用马夫瑞单抗（MASH-COVID）：一项研究者发起的多中心、双盲、随机、安慰剂对照试验。
Lancet Rheumatol. 2021 Jun;3(6):e410-e418. doi: 10.1016/S2665-9913(21)00070-9. Epub 2021 Mar 17.
3
A neutrophil activation signature predicts critical illness and mortality in COVID-19.中性粒细胞激活特征可预测 COVID-19 患者的重症和死亡风险。
Blood Adv. 2021 Mar 9;5(5):1164-1177. doi: 10.1182/bloodadvances.2020003568.
4
Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup.新冠病毒肺炎中白细胞介素-6受体抑制——冷却炎症“汤液”
N Engl J Med. 2021 Apr 22;384(16):1564-1565. doi: 10.1056/NEJMe2103108. Epub 2021 Feb 25.
5
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial.阿那白滞素与常规治疗对新冠肺炎合并轻至中度肺炎成人住院患者的疗效（CORIMUNO-ANA-1）：一项随机对照试验
Lancet Respir Med. 2021 Mar;9(3):295-304. doi: 10.1016/S2213-2600(20)30556-7. Epub 2021 Jan 22.
6
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.巴瑞替尼联合瑞德西韦治疗住院的新冠成年患者
N Engl J Med. 2021 Mar 4;384(9):795-807. doi: 10.1056/NEJMoa2031994. Epub 2020 Dec 11.
7
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.不同的炎症特征将 COVID-19 与流感区分开来，细胞因子风暴的贡献有限。
Sci Adv. 2020 Dec 9;6(50). doi: 10.1126/sciadv.abe3024. Print 2020 Dec.
8
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.严重和危重新冠肺炎中的细胞因子升高：快速系统评价、荟萃分析，并与其他炎症综合征比较。
Lancet Respir Med. 2020 Dec;8(12):1233-1244. doi: 10.1016/S2213-2600(20)30404-5. Epub 2020 Oct 16.
9
An inflammatory cytokine signature predicts COVID-19 severity and survival.炎症细胞因子特征可预测 COVID-19 严重程度和存活情况。
Nat Med. 2020 Oct;26(10):1636-1643. doi: 10.1038/s41591-020-1051-9. Epub 2020 Aug 24.
10
Longitudinal analyses reveal immunological misfiring in severe COVID-19.纵向分析揭示了重症 COVID-19 中的免疫失调。
Nature. 2020 Aug;584(7821):463-469. doi: 10.1038/s41586-020-2588-y. Epub 2020 Jul 27.